Search

Your search keyword '"Chalasani, Naga"' showing total 232 results

Search Constraints

Start Over You searched for: Author "Chalasani, Naga" Remove constraint Author: "Chalasani, Naga" Publisher elsevier bv Remove constraint Publisher: elsevier bv
232 results on '"Chalasani, Naga"'

Search Results

1. Randomized-controlled trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

4. Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD

7. Vancomycin-Induced Liver Injury, DRESS, and HLA-A*32:01

8. Genetic risk factors for NAFLD and clinically significant fibrosis in persons living with HIV

11. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

12. Fibrosis Progression Rate in Biopsy-proven Nonalcoholic Fatty Liver Disease among People with Diabetes versus People without Diabetes: A Multicenter Study

14. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease

16. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate

20. Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury

26. 528: THE MULTI-TARGET HEPATOCELLULAR CARCINOMA BLOOD TEST PROVIDES HIGH SENSITIVITY FOR DETECTING EARLY-STAGE HEPATOCELLULAR CARCINOMA ACROSS IMPORTANT PATIENT SUBGROUPS

29. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers

30. Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis

32. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma

33. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma

35. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

37. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

38. Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis

40. Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

45. Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development

49. Quantitative magnetic resonance cholangiopancreatography imaging in patients with primary sclerosing cholangitis - feasibility and preliminary analysis for prediction of clinical outcomes

Catalog

Books, media, physical & digital resources